| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Application of a decision analytic framework for adoption of clinical trial results: are the data regarding TARGIT-A IORT ready for prime time?
|
Esserman, L. J.
|
|
2014
|
144 |
2 |
p. 371-378
|
artikel
|
| 2 |
Assessment of microtubule-associated protein (MAP)-Tau expression as a predictive and prognostic marker in TACT; a trial assessing substitution of sequential docetaxel for FEC as adjuvant chemotherapy for early breast cancer
|
Irshad, S.
|
|
2014
|
144 |
2 |
p. 331-341
|
artikel
|
| 3 |
Axillary concordance between superficial and deep sentinel node mapping material injections in breast cancer patients: systematic review and meta-analysis of the literature
|
Sadeghi, Ramin
|
|
2014
|
144 |
2 |
p. 213-222
|
artikel
|
| 4 |
Benefit from anthracyclines in relation to biological profiles in early breast cancer
|
Rocca, Andrea
|
|
2013
|
144 |
2 |
p. 307-318
|
artikel
|
| 5 |
Bone mineral density and circulating biomarkers in the BIG 1-98 trial comparing adjuvant letrozole, tamoxifen and their sequences
|
DeCensi, Andrea
|
|
2014
|
144 |
2 |
p. 321-329
|
artikel
|
| 6 |
Characterisation of HER heterodimers in breast cancer using in situ proximity ligation assay
|
Barros, Fabrício F. T.
|
|
2014
|
144 |
2 |
p. 273-285
|
artikel
|
| 7 |
Comparative safety of cardiovascular medication use and breast cancer outcomes among women with early stage breast cancer
|
Boudreau, Denise M.
|
|
2014
|
144 |
2 |
p. 405-416
|
artikel
|
| 8 |
Dermcidin expression is associated with disease progression and survival among breast cancer patients
|
Brauer, Heather Ann
|
|
2014
|
144 |
2 |
p. 299-306
|
artikel
|
| 9 |
Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study
|
Ayme, Aurélie
|
|
2014
|
144 |
2 |
p. 379-389
|
artikel
|
| 10 |
Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer
|
Hosoda, Mitsuchika
|
|
2014
|
144 |
2 |
p. 249-261
|
artikel
|
| 11 |
Digoxin use and risk of invasive breast cancer: evidence from the Nurses’ Health Study and meta-analysis
|
Ahern, Thomas P.
|
|
2014
|
144 |
2 |
p. 427-435
|
artikel
|
| 12 |
Disseminated tumor cells as a monitoring tool for adjuvant therapy in patients with primary breast cancer
|
Gruber, Ines
|
|
2014
|
144 |
2 |
p. 353-360
|
artikel
|
| 13 |
Early changes in [18F]FDG incorporation by breast cancer cells treated with trastuzumab in normoxic conditions: role of the Akt-pathway, glucose transport and HIF-1α
|
Fleming, Ian N.
|
|
2014
|
144 |
2 |
p. 241-248
|
artikel
|
| 14 |
Effect of adjuvant endocrine therapy on hormonal levels in premenopausal women with breast cancer: the ProBONE II study
|
Hadji, Peyman
|
|
2014
|
144 |
2 |
p. 343-351
|
artikel
|
| 15 |
Effects of exercise dose and type on sleep quality in breast cancer patients receiving chemotherapy: a multicenter randomized trial
|
Courneya, Kerry S.
|
|
2014
|
144 |
2 |
p. 361-369
|
artikel
|
| 16 |
Erratum to: Benefit from anthracyclines in relation to biological profiles in early breast cancer
|
Rocca, Andrea
|
|
2014
|
144 |
2 |
p. 319
|
artikel
|
| 17 |
Evaluation of the RHINO gene for breast cancer predisposition in Finnish breast cancer families
|
Heikkinen, Tuomas
|
|
2014
|
144 |
2 |
p. 437-441
|
artikel
|
| 18 |
Expert perspectives on biosimilar monoclonal antibodies in breast cancer
|
Cortés, J.
|
|
2014
|
144 |
2 |
p. 233-239
|
artikel
|
| 19 |
First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer
|
Shih, Ya-Chen Tina
|
|
2014
|
144 |
2 |
p. 417-425
|
artikel
|
| 20 |
mTORC1/C2 and pan-HDAC inhibitors synergistically impair breast cancer growth by convergent AKT and polysome inhibiting mechanisms
|
Wilson-Edell, Kathleen A.
|
|
2014
|
144 |
2 |
p. 287-298
|
artikel
|
| 21 |
Survival from breast cancer in patients with CHEK2 mutations
|
Huzarski, T.
|
|
2014
|
144 |
2 |
p. 397-403
|
artikel
|
| 22 |
Therapeutic potential of the dual EGFR/HER2 inhibitor AZD8931 in circumventing endocrine resistance
|
Morrison, Gladys
|
|
2014
|
144 |
2 |
p. 263-272
|
artikel
|
| 23 |
The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis
|
Petrelli, Fausto
|
|
2014
|
144 |
2 |
p. 223-232
|
artikel
|
| 24 |
The value of substratified combined imaging assessment with mammography and ultrasonography for Chinese women with palpable breast masses
|
Li, Jiguang
|
|
2014
|
144 |
2 |
p. 391-396
|
artikel
|
Tijdschrift beschrijving